Cargando…

A Cannabinoid Receptor Agonist N-Arachidonoyl Dopamine Inhibits Adipocyte Differentiation in Human Mesenchymal Stem Cells

Endocannabinoids can affect multiple cellular targets, such as cannabinoid (CB) receptors, transient receptor potential cation channel, subfamily V, member 1 (TRPV1) and peroxisome proliferator-activated receptor γ (PPARγ). The stimuli to induce adipocyte differentiation in hBM-MSCs increase the gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Seyeon, Yi, Sodam, Seo, Won Jong, Lee, Myeong Jung, Song, Young Keun, Baek, Seung Yong, Yu, Jinha, Hong, Soo Hyun, Lee, Jinyoung, Shin, Dong Wook, Jeong, Lak Shin, Noh, Minsoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Applied Pharmacology 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428713/ https://www.ncbi.nlm.nih.gov/pubmed/25995819 http://dx.doi.org/10.4062/biomolther.2014.137

Ejemplares similares

The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption
por: Ding, Weihua, et al.
Publicado: (2023)

N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities
por: Grabiec, Urszula, et al.
Publicado: (2017)

Author Correction: The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption
por: Ding, Weihua, et al.
Publicado: (2023)

Chronic Administration of Cannabinoid Receptor 2 Agonist (JWH-133) Increases Ectopic Ovarian Tumor Growth and Endocannabinoids (Anandamide and 2-Arachidonoyl Glycerol) Levels in Immunocompromised SCID Female Mice
por: Blanton, Henry L., et al.
Publicado: (2022)

Arachidonoyl-Phospholipid Remodeling in Proliferating Murine T Cells
por: Tomita, Michiyo, et al.
Publicado: (2004)

Arachidonoyl-Specific Diacylglycerol Kinase ε and the Endoplasmic Reticulum
por: Nakano, Tomoyuki, et al.
Publicado: (2016)

Effect of N-arachidonoyl-l-serine on human cerebromicrovascular endothelium()
por: Kino, Tomoyuki, et al.
Publicado: (2016)

Influence of N-Arachidonoyl Dopamine and N-Docosahexaenoyl Dopamine on the Expression of Neurotrophic Factors in Neuronal Differentiated Cultures of Human Induced Pluripotent Stem Cells under Conditions of Oxidative Stress
por: Novosadova, Ekaterina, et al.
Publicado: (2022)

Cyclin-Dependent Kinase 5 Inhibitor Butyrolactone I Elicits a Partial Agonist Activity of Peroxisome Proliferator-Activated Receptor γ
por: Ahn, Sungjin, et al.
Publicado: (2020)

Design and Synthesis of 2,6-Disubstituted-4′-Selenoadenosine-5′-N,N-Dimethyluronamide Derivatives as Human A(3) Adenosine Receptor Antagonists
por: Choi, Hongseok, et al.
Publicado: (2021)

An innovative electrochemical immuno-platform towards ultra-sensitive monitoring of 2-arachidonoyl glycerol in samples from rats with sleep deprivation: bioanalysis of endogenous cannabinoids using biosensor technology
por: Kohansal, Fereshteh, et al.
Publicado: (2022)

Endocannabinoid 2-arachidonoyl glycerol increases the transcription of daf-7 in ASI neurons
por: Galles, Celina, et al.
Publicado: (2018)

Impaired adrenergic agonist-dependent beige adipocyte induction in obese mice
por: SHIN, Woongchul, et al.
Publicado: (2019)

The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
por: Liu, Xiaoshuang, et al.
Publicado: (2019)

Bavachin from Psoralea corylifolia Improves Insulin-Dependent Glucose Uptake through Insulin Signaling and AMPK Activation in 3T3-L1 Adipocytes
por: Lee, Hyejin, et al.
Publicado: (2016)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis
por: Tokumura, Akira, et al.
Publicado: (2009)

Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion
por: Rong, Xin, et al.
Publicado: (2015)

Erratum: Endocannabinoid 2-arachidonoyl glycerol increases the transcription of daf-7 in ASI neurons
Publicado: (2019)

NO(●) Represses the Oxygenation of Arachidonoyl PE by 15LOX/PEBP1: Mechanism and Role in Ferroptosis
por: Mikulska-Ruminska, Karolina, et al.
Publicado: (2021)

Cannabinoids: A New Group of Agonists of PPARs
por: Sun, Yan, et al.
Publicado: (2007)

The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
por: Terzian, Ana Luisa, et al.
Publicado: (2011)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Dopamine Receptors in Human Adipocytes: Expression and Functions
por: Borcherding, Dana C., et al.
Publicado: (2011)

Dopamine Agonists and Pathologic Behaviors
por: Kelley, Brendan J., et al.
Publicado: (2012)

Dopamine Agonists for Pituitary Adenomas
por: Cooper, Odelia, et al.
Publicado: (2018)

The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways
por: Bradshaw, Heather B, et al.
Publicado: (2009)

GPR18 undergoes a high degree of constitutive trafficking but is unresponsive to N-Arachidonoyl Glycine
por: Finlay, David B., et al.
Publicado: (2016)

Assessment of the Abuse Liability of Synthetic Cannabinoid Agonists JWH-030, JWH-175, and JWH-176
por: Tampus, Reinholdgher, et al.
Publicado: (2015)

Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
por: Nagappan, Arulkumar, et al.
Publicado: (2019)

Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
por: Gavryushov, Sergei, et al.
Publicado: (2023)

High hopes for cannabinoid agonists in the treatment of rheumatic diseases
por: Staunton, Caroline A, et al.
Publicado: (2014)

Long-term Outcome of Microscopic Transsphenoidal Surgery for Prolactinomas as an Alternative to Dopamine Agonists
por: Park, Kawngwoo, et al.
Publicado: (2021)

Effects of TRPV1 Activation by Capsaicin and Endogenous N-Arachidonoyl Taurine on Synaptic Transmission in the Prefrontal Cortex
por: Zhang, Mingyue, et al.
Publicado: (2020)

Cannabinoids Regulate Bcl-2 and Cyclin D2 Expression in Pancreatic β Cells
por: Kim, Jihye, et al.
Publicado: (2016)

GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A(2A) Adenosine Receptor
por: Shiriaeva, Anna, et al.
Publicado: (2022)

The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008)

Impulse control disorders and dopamine agonists
por: Martins, D., et al.
Publicado: (2021)

Experience with Dopamine Agonists in the Treatment of Prolactinomas
por: Barabash, Nadiya Ye., et al.
Publicado: (2022)

Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms
por: Takheaw, Nuchjira, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ffbnou0id1n99dd7i9vrdieiru